Table 1.
Treatment | Body weight (g) | Plasma glucose (mg/dl) | ||
---|---|---|---|---|
|
|
|||
Onset of study | End of study | Onset of study | End of study | |
Con | 303.10 ± 4.51 | 308.40 ± 6.82 | 118.40 ± 1.38 | 120.20 ± 1.28 |
DM | 302.30 ± 5.31 | 241.70 ± 4.29** | 116.40 ± 1.36 | 612.70 ± 3.73** |
DM + AST (10) | 299.80 ± 5.68 | 268.60 ±6.12## | 115.80 ± 1.27 | 321.10 ± 3.21## |
DM + AST (20) | 301.80 ± 6.68 | 273.70 ± 6.28## | 111.20 ± 2.31 | 304.70 ± 3.18## |
DM + AST (40) | 304.20 ± 5.26 | 286.40 ± 6.88## | 109.80 ± 2.41 | 298.50 ± 3.82## |
P<0.01 compared with Con group;
P<0.01 compared with DM group.
Con, control group; DM, diabetes group; DM + AST (10), astaxanthin (10 mg/kg)-treated group; DM + AST (20), astaxanthin (20 mg/kg)-treated group; DM + AST (40), astaxanthin (40 mg/kg)-treated group.